Table 1 Clinicopathologic features of mesonephric and mesonephric-like carcinomas.
Site of origin | Case ID | Age at diagnosis (years) | FIGO stage (2009) | Sample class | Tumor size (cm) | Tumor histology | Recurrence site |
|---|---|---|---|---|---|---|---|
Mesonephric cervix | CX8 | 65 | IB1 | Primary | 2.3 | Mesonephric | Liver, brain |
CX17 | 43 | IIB | Primary | 4.3 | Mesonephric | – | |
CX26 | 30 | IB1 | Primary | 8.6 | Mixed mesonephric and endometrioid | – | |
CX33 | 75 | IB | Primary | 4.7 | Mesonephric | Vagina | |
CX44 | 51 | IB1 | Metastasis (lung) | N/A | Mesonephric | Lung | |
CX58 | 72 | IIB | Metastasis (lung) | 6.4 | Mesonephric carcinosarcoma | Lung | |
CX62 | 70 | IV | Primary | 8.5 | Mesonephric | Pelvis | |
CX67 | 55 | IIA | Primary | 2.0 | Mesonephric | Vagina | |
Mesonephric-like ovary | OV2 | 66 | IIIC | Primary | 5.4 | Mixed mesonephric-like and serous borderline tumor | Left rectal mesentery |
OV19 | 62 | N/A | Metastasis (bowel) | 7.5 | Mixed mesonephric-like and low-grade serous carcinoma | Bowel | |
OV21 | 52 | IA | Primary | 18.5 | Mixed mesonephric-like and mucinous borderline tumor | – | |
OV34 | 76 | IVB | Primary | 13.1 | Mesonephric-like | – | |
OV50 | 67 | N/A | Primary | N/A | Mesonephric-like | – | |
OV57 | 66 | IIB | Metastasis (pelvic recurrence) | 4.0 | Mesonephric-like | Pelvis | |
OV66 | 45 | IIIA | Primary | 18.0 | Mesonephric-like | Ovary, lymph node | |
OV70 | 54 | IIIC | Primary | 15.1 | Mesonephric-like | Lung, liver | |
OV73 | 63 | IV | Metastasis (liver) | N/A | Mesonephric-like | Liver | |
OV74 | 61 | IV | Primary | 4.1 | Mixed mesonephric-like and serous borderline tumor/low-grade serous carcinoma | Peritoneal and omental carcinomatosis, lung, bowel, liver, abdominal and intrathoracic lymph nodes | |
OV75 | 60 | IC | Primary | 10.1 | Mixed mesonephric-like and mucinous borderline tumor | – | |
OV77 | 36 | IA | Metastasis (lung) | 14.0 | Mesonephric-like | Lung, pubic bone | |
OV79 | 76 | IC | Primary | 3.5 | Mesonephric-like carcinosarcoma | Iliopsoas | |
OV80 | 59 | IIB | Metastasis (bladder) | N/A | Mesonephric-like | Bladder | |
OV81 | 71 | IC | Primary | 8.0 | Mesonephric-like | – | |
Mesonephric-like endometrium | EM1 | 71 | IIIC | Primary | 3.0 | Mesonephric-like | – |
EM36 | 60 | IIIC | Metastasis (brain) | 4.5 | Mesonephric-like | Lung, brain | |
EM52 | 57 | IB | Primary | 2.8 | Mesonephric-like | Lung | |
EM59 | 51 | IC | Metastasis (lung) | 3.5 | Mesonephric-like | Lung | |
EM61 | 58 | IA | Primary | 4.5 | Mesonephric-like | Lymph nodes, abdomen | |
EM63 | 67 | IVA | Primary | 5.7 | Mesonephric-like carcinosarcoma | Abd pelvic | |
EM64 | 62 | IA | Primary | 3.0 | Mesonephric-like | Pelvic lymph nodes, omentum | |
EM65 | 59 | IA | Primary | 7.5 | Mesonephric-like carcinosarcoma | Bone, liver | |
EM68 | 61 | IV | Primary | 4.0 | Mesonephric-like | Lung | |
EM69 | 48 | IA | Primary | 2.6 | Mesonephric-like | Vagina apex | |
EM71 | 58 | N/A | Primary | N/A | Mesonephric-like | Lung | |
EM72 | 52 | IV | Metastasis (lung) | 8.0 | Mesonephric-like | Lung | |
EM76 | 61 | IV | Metastasis (vaginal recurrence) | 10.5 | Mesonephric-like | Vagina, lung |
